JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.

Altre lingue Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Azioni

688076

CNE1000051X5

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 27/06/2024			Variaz. 5gg	Var. 1 gen.
78,4 ^CNY	-1,36%		+27,77%	+74,42%

22/04	Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
23/02	Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2024.	21/05
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Sinopep-Allsino Biopharmaceutical's Raw Drug Material Gets OK to Submit Drug Application to US FDA; Shares Up 4%	19/12
Sinopep-Allsino Biopharmaceutical Gets Nod to Issue Convertible Bonds	17/11
Sinopep-Allsino’s Hypertension Drug Shortlisted for China’s Drug Procurement Program	08/11
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	20/10/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(XSSC:688076) added to S&P Global BMI Index	18/09/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23
Jiande Xinglian Enterprise Management Co., Ltd. entered into an agreement to acquire 4.84% in Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from Jiande Wuxing Biological Technology Co., Ltd. for CNY 369 million.	08/06/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	21/04/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 300 million in funding	21/04/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	18/10/22
Sinopep-Allsino Biopharma Unit to Buy 9% Stake in Biotech Firm	28/09/22
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Zhejiang Zhongcheng Pharmaceutical Co., Ltd. agreed to acquire 45% stake in Hangzhou Xinbosi Biopharmaceutical Co., Ltd. from Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. for CNY 13.5 million.	30/06/22
Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2022.	21/05/22
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange Composite Index	20/05/22
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange A Share Index	20/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Azioni

688076

CNE1000051X5

Altre lingue

Filtri